Pal Pacher
Pal Pacher
National Institutes of Health, Bethesda; Semmelweis University, Budapest
Email verificata su - Home page
Citata da
Citata da
Nitric oxide and peroxynitrite in health and disease
P Pacher, JS Beckman, L Liaudet
Physiological reviews 87 (1), 315-424, 2007
The endocannabinoid system as an emerging target of pharmacotherapy
P Pacher, S Bátkai, G Kunos
Pharmacological reviews 58 (3), 389-462, 2006
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity
D Osei-Hyiaman, M DePetrillo, P Pacher, J Liu, S Radaeva, S Bátkai, ...
The Journal of clinical investigation 115 (5), 1298-1305, 2005
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol
PAL Pacher, A Nivorozhkin, C Szabó
Pharmacological reviews 58 (1), 87-114, 2006
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
G Haskó, J Linden, B Cronstein, P Pacher
Nature reviews Drug discovery 7 (9), 759-770, 2008
Activation of the peripheral endocannabinoid system in human obesity
S Engeli, J Böhnke, M Feldpausch, K Gorzelniak, J Janke, S Bátkai, ...
Diabetes 54 (10), 2838-2843, 2005
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
OV Evgenov, P Pacher, PM Schmidt, G Haskó, HHHW Schmidt, JP Stasch
Nature reviews Drug discovery 5 (9), 755-768, 2006
CD39 and CD73 in immunity and inflammation
L Antonioli, P Pacher, ES Vizi, G Haskó
Trends in molecular medicine 19 (6), 355-367, 2013
Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats
P Pacher, T Nagayama, P Mukhopadhyay, S Bátkai, DA Kass
Nature protocols 3 (9), 1422, 2008
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
M Blüher, S Engeli, N Klöting, J Berndt, M Fasshauer, S Bátkai, P Pacher, ...
Diabetes 55 (11), 3053-3060, 2006
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors
N Agarwal, P Pacher, I Tegeder, F Amaya, CE Constantin, GJ Brenner, ...
Nature neuroscience 10 (7), 870-879, 2007
Immunity, inflammation and cancer: a leading role for adenosine
L Antonioli, C Blandizzi, P Pacher, G Haskó
Nature Reviews Cancer 13 (12), 842-857, 2013
Evidence for novel cannabinoid receptors
M Begg, P Pacher, S Bátkai, D Osei-Hyiaman, L Offertáler, FM Mo, J Liu, ...
Pharmacology & therapeutics 106 (2), 133-145, 2005
Endocannabinoid signaling at the periphery: 50 years after THC
M Maccarrone, I Bab, T Bíró, GA Cabral, SK Dey, V Di Marzo, JC Konje, ...
Trends in pharmacological sciences 36 (5), 277-296, 2015
Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease
JP Stasch, P Pacher, OV Evgenov
Circulation 123 (20), 2263-2273, 2011
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P Pacher, R Mechoulam
Progress in lipid research 50 (2), 193-211, 2011
Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?
P Pacher, V Kecskemeti
Current pharmaceutical design 10 (20), 2463-2475, 2004
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies
P Pacher, IG Obrosova, JG Mabley, C Szabó
Current medicinal chemistry 12 (3), 267-275, 2005
Resveratrol induces mitochondrial biogenesis in endothelial cells
A Csiszar, N Labinskyy, JT Pinto, P Ballabh, H Zhang, G Losonczy, ...
American Journal of Physiology-Heart and Circulatory Physiology 297 (1), H13-H20, 2009
Role of the peroxynitrite-poly (ADP-ribose) polymerase pathway in human disease
P Pacher, C Szabo
The American journal of pathology 173 (1), 2-13, 2008
Il sistema al momento non puň eseguire l'operazione. Riprova piů tardi.
Articoli 1–20